A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
New reference limits for cardiac troponin T and N-terminal b-type natriuretic propeptide in elders
Tekijät: Heikkilä Elisa, Katajamäki Taina, Salminen Marika, Irjala Kerttu, Viljanen Anna, Koivula Marja-Kaisa, Pulkki Kari, Isoaho Raimo, Kivelä Sirkka-Liisa, Viitanen Matti, Löppönen Minna, Vahlberg Tero, Viikari Laura
Kustantaja: Elsevier
Julkaisuvuosi: 2024
Journal: Clinica Chimica Acta
Tietokannassa oleva lehden nimi: Clinica Chimica Acta
Artikkelin numero: 117844
Vuosikerta: 556
ISSN: 0009-8981
eISSN: 1873-3492
DOI: https://doi.org/10.1016/j.cca.2024.117844
Verkko-osoite: https://doi.org/10.1016/j.cca.2024.117844
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/387045419
Background and aims: Our aim was to define reference limits for cardiac troponin T (cTnT) and N-terminal pro B-type natriuretic peptide (proBNP) that would better reflect their concentrations in older people. In addition, the incidence of acute myocardial infarctions (AMIs) was studied using these reference limits in an older population with and without previous heart diseases.
Materials and methods: A population-based study with a ten-year follow-up. The reference population was formed by 763 individuals aged over 64 years, with no diagnoses of heart or kidney diseases.
Results: There was a significant increase in cTnT and proBNP concentrations with age. The 99 % reference limits for cTnT were 25 ng/L, 28 ng/l, 38 ng/l, and 71 ng/l for men in five-year-intervals starting from 64 to 69 years to 80 years and older, and 18 ng/L, 22 ng/l, 26 ng/l, and 52 ng/L for women, respectively. The 97.5 % reference limits for proBNP were 272 ng/L, 287 ng/l, 373 ng/l and 686 ng/L for men, and 341 ng/L, 377 ng/l, 471 ng/l, and 794 ng/L for women, respectively. Elevated proBNP was statistically significantly associated with future AMIs in subjects with and without a previous heart disease.
Conclusions: Age-specific reference limits for cTnT and proBNP are needed to better evaluate cardiac symptoms.
Ladattava julkaisu This is an electronic reprint of the original article. |